![]() |
市场调查报告书
商品编码
1666251
亚太地区干眼产品市场预测至 2031 年 - 区域分析 - 按产品、剂型、类型和配销通路Asia Pacific Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product, Dosage Form, Type, and Distribution Channel |
2023年亚太地区干眼症产品市值为11.0146亿美元,预计2031年将达到16.4184亿美元;预计 2023 年至 2031 年的复合年增长率为 5.1%。
提高眼部护理意识的措施推动亚太干眼产品市场发展
近年来,人们采取了各种措施来提高对眼疾的认识和教育,促使患者获得合适的药物和治疗。例如,作为可避免失明计画 (ABP)(于 2021 年启动)的一部分,诺华于 2022 年与撒哈拉以南非洲和东南亚的合作伙伴合作,让这些国家能够获得其眼部护理产品。
国际防盲机构(IAPB)于2022年发起了「爱护你的眼睛」全球运动,以提高人们对眼健康社会经济重要性的认识。该活动呼吁各国政府和全球机构支持眼健康。 IAPB 重点关注印度和世界各地的计划和倡议,这些计划和倡议重点是提供方便、可用且价格合理的眼科护理。 「爱护眼睛」计画也呼吁改变法规并投入资金,到2030年让人们能够获得、获得并且负担得起眼部保健服务。
2022 年 12 月,防盲研究组织选定犹他大学约翰·A·莫兰眼科中心,向其提供每年 115,000 美元的无限制资助,用于支持眼科研究。截至 2021 年 12 月,美国国立卫生研究院 (NIH) 支持印度阿拉文眼科医院与凯洛格眼科中心建立合作伙伴关係,为眼科保健专业人员制定临床研究培训计画。作为此项计划的一部分,美国国立卫生研究院拨款 110 万美元支持安娜堡(美国)的培训项目,并为参与者提供种子资金。此外,2020年印度-美国合作视觉研究计画致力于推进科学技术,以了解、预防和治疗致盲视觉障碍、眼部疾病及其相关併发症。印度生物技术部和美国国家眼科研究所资助了这项研究计画。
因此,增加用于眼部保健研究的资金和加强宣传眼保健意识的力度可能会在未来几年为干眼症产品市场创造新的机会。
亚太干眼产品市场概览
亚太干眼产品市场分为中国、印度、日本、韩国、澳洲和亚太其他地区。可能推动该地区市场成长的因素包括因长时间使用电脑导致年轻人干眼症发病率不断上升、政府对眼部保健的支持不断增加、以及眼科解决方案的不断发展。根据美国国立卫生研究院的数据,在中国,每年约有 20-30% 的人被诊断出患有干眼症。中国干眼产品市场竞争相当激烈,国内外药厂都有参与。 Novaliq与江苏恆瑞医药建立策略合作,共同生产、开发和商业化用于治疗干眼症的NOV03。 2021年12月,恆瑞在治疗睑板腺功能障碍相关干眼症的SHR8058(NOV03)关键3期临床试验中取得正面成果;该试验在中国各地17个地点进行。该中国公司预计将在中国和东南亚地区分销这些产品。
亚太干眼产品市场营收及 2031 年预测(百万美元)
亚太地区干眼产品市场区隔
亚太干眼产品市场分为产品、剂型、类型、配销通路和国家。
根据产品,亚太干眼产品市场分为人工泪液、抗发炎药、泪点塞、促泌剂、口服欧米茄补充剂等。 2023 年,人工泪液占据了亚太地区干眼症产品市场的最大份额。此外,泪点塞部分又细分为可溶解和可拆卸。
就剂型而言,亚太干眼症产品市场分为眼药水、凝胶、胶囊及锭剂等。 2023 年,眼药水部门占据了亚太地区干眼产品市场的最大份额。
根据类型,亚太干眼症产品市场分为非处方药和处方药。 2023 年,OTC 部门占据了亚太地区干眼症产品市场的较大份额。
根据配销通路,亚太干眼产品市场分为零售药局、医院药局和网路药局。 2023 年,零售药局部门占据了亚太地区干眼产品市场最大的份额。
根据国家/地区,亚太干眼产品市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2023年,中国占据亚太地区干眼症产品市场的主导份额。
参天製药有限公司、强生公司、OASIS Medical、URSAPHARM Arzneimittel GmbH、乐敦製药有限公司、OCuSOFT Inc、博士伦医疗公司、艾伯维公司、Prestige Consumer Healthcare Inc、Farmigea SpA 和爱尔康公司是亚太地区干眼症产品市场的一些领先公司。
The Asia Pacific dry eye products market was valued at US$ 1,101.46 million in 2023 and is expected to reach US$ 1,641.84 million by 2031; it is estimated to register a CAGR of 5.1% from 2023 to 2031.
Increasing Initiatives for Eye Care Awareness Boost Asia Pacific Dry Eye Products Market
In recent years, various initiatives have been taken to create awareness and educate people regarding eye diseases, prompting patients to access suitable medications and treatments. For instance, as a part of the Avoidable Blindness Program (ABP) (launched in 2021), Novartis worked with its partners across Sub-Saharan Africa and Southeast Asia to access to its eye care products in 2022. ABP focuses on moderate to severe vision damage caused by glaucoma and retinal conditions that are responsible for a large proportion of preventable blindness.
The International Agency for the Prevention of Blindness (IAPB) launched the global campaign named "Love Your Eyes" in 2022 to raise awareness of the socioeconomic importance of eye health. The campaign calls upon governments and global institutions to support eye health. The IAPB emphasizes programs and initiatives in India and the world, which promptly focus on offering accessible, available, and affordable eye care. The "Love Your Eyes" program also calls for regulation changes and funding to make eye care accessible, available, and affordable by 2030.
In December 2022, Research to Prevent Blindness selected the John A. Moran Eye Center at the University of Utah for the unlimited annual grant of US$ 115,000 to support eye research. As of December 2021, the National Institutes of Health (NIH) supported a partnership between Aravind Eye Hospital (India) and Kellogg Eye Center to develop a clinical research training program for eyecare professionals. As a part of this initiative, the NIH awarded US$ 1.1 million to support training programs in Ann Arbor (US) and offered seed funding for the participants. In addition, the India-US Collaborative Vision Research Program 2020 focuses on advancing science and technology to understand, prevent, and treat blinding visual disorders, eye diseases, and associated complications. The Indian Department of Biotechnology and the US National Eye Institute funded this research program.
Thus, increasing funds for eyecare research and rising initiatives to spread awareness about eye care are likely to create new opportunities in the dry eye product market in the coming years.
Asia Pacific Dry Eye Products Market Overview
The Asia Pacific dry eye products market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. The factors that are likely to contribute to the market growth in this region include the increasing incidence of DED among young people due to prolonged usage of computers, growing government support for eye health, and ongoing developments in ophthalmic solutions. According to NIH, in China, ~20-30% of people are diagnosed with dry eye conditions every year. The dry eye products market in China is quite competitive, with the presence of both domestic and international pharmaceutical companies. Novaliq has established a strategic cooperation with Jiangsu Hengrui Pharmaceuticals to manufacture, develop, and commercialize NOV03 for the treatment of dry eye disease. In December 2021, Hengrui obtained positive outcomes from the critical Phase 3 clinical trial of SHR8058 (NOV03) for the treatment of dry eye disease linked with meibomian gland dysfunction; the trial was conducted at 17 sites across China. The Chinese firm is expected to distribute these products across China and Southeast Asia.
Asia Pacific Dry Eye Products Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Dry Eye Products Market Segmentation
The Asia Pacific dry eye products market is categorized into product, dosage form, type, distribution channel, and country.
Based on product, the Asia Pacific dry eye products market is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held the largest Asia Pacific dry eye products market share in 2023. Furthermore, the anti-inflammatory drugs segment is subcategorized into cyclosporine, corticosteroid, and others. Additionally, the punctal plugs segment is subsegmented into dissolvable and removable.
In terms of dosage form, the Asia Pacific dry eye products market is segmented into eye drops, gel, capsules and tablets, and others. The eye drops segment held the largest Asia Pacific dry eye products market share in 2023.
By type, the Asia Pacific dry eye products market is bifurcated into OTC and prescription. The OTC segment held a larger Asia Pacific dry eye products market share in 2023.
Based on distribution channel, the Asia Pacific dry eye products market is categorized into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment held the largest Asia Pacific dry eye products market share in 2023.
Based on country, the Asia Pacific dry eye products market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific dry eye products market share in 2023.
Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Prestige Consumer Healthcare Inc, Farmigea SpA, and Alcon AG are some of the leading companies operating in the Asia Pacific dry eye products market.